Find your trial
pipeline in
90 seconds.
AI eligibility parsing matches patients to active trials before the pre-screening call. Site coordinators, sponsors, and CROs cut enrollment timelines by 74% on average.
Numbers before
narratives.
The funnel that
doesn't leak.
Traditional recruitment loses patients at every stage — from EHR to coordinator call to consent. Enroll seals each drop-off point with AI that works while your team sleeps.
From coordinators
who've been in the room.
Our Phase III was 6 months behind target. We onboarded Enroll on a Thursday. By the following Friday, we had 4 new rescue sites activated and 89 pre-qualified patients in queue. We hit enrollment in 11 weeks.
We used to spend 3 hours per patient on pre-screening calls. Enroll flags qualified patients before I open the chart. I'm running 4 studies with the same bandwidth I used to give to 2.
Sponsors burned $2M on site activation costs and discovered 70% of patients failed screen four months in. Enroll catches that before activation. The ROI math is not complicated.
The genomic marker we were screening for appeared in fewer than 3% of the target population at our sites. Enroll's biomarker-aware matching found us 47 qualified patients across 6 sites we hadn't considered.
2026 Enrollment
Benchmark Report.
Industry enrollment velocity benchmarks across 12 therapeutic areas, 4 trial phases, and 6 geographic markets. 89 trials analyzed. Know where your timeline stands before the board meeting.